Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506

Transplantation. 1988 Jan;45(1):206-9. doi: 10.1097/00007890-198801000-00042.

Abstract

FK506, an immunosuppresant, was isolated from Streptomyces tsukubaensis. Intramuscular administration of FK506 (0.32 mg/kg or more) 5 days a week for two weeks after grafting prolonged the acceptance time of F344 skin allograft to WKA rats. Similar results were obtained with cyclosporine at 32 mg/kg or more, but other immunosuppressives (i.e., prednisolone, azathioprine, and bredinin) gave only a marginal prolongation. The prolonging effect of FK506 was obtained in various donor-recipient combinations across a major or minor histocompatibility barrier. The agent also prolonged the acceptance time of mouse skin xenografts to rats. Furthermore, maintenance doses of 3.2 or 0.32 mg/kg twice a week after an initial 14-day treatment with the agent at 3.2 mg/kg gave graft survival as long as the treatment was continued for more than 120 days. Our findings show that FK506 has a potent immunosuppressive effect in rats and suggest that the agent merits further investigation.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Cyclosporins / pharmacology
  • Graft Survival / drug effects*
  • Immunosuppressive Agents / pharmacology*
  • Male
  • Mice
  • Mice, Inbred C57BL / immunology
  • Pyridines / pharmacology
  • Rats
  • Rats, Inbred Strains / immunology
  • Skin Transplantation*
  • Tacrolimus
  • Transplantation, Heterologous
  • Transplantation, Homologous

Substances

  • Cyclosporins
  • Immunosuppressive Agents
  • Pyridines
  • Tacrolimus